Advances and challenges in retinoid delivery systems in regenerative and therapeutic medicine

• Autor(a) principal: Ferreira, Raquel
• Data de Publicação: 2020
• Outros Autores: Napoli, Joseph, Enver, Tariq, Bernardino, Liliana, Ferreira, Lino
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• DOI: 10.1038/s41467-020-18042-2
• Texto Completo: http://hdl.handle.net/10316/92473; https://doi.org/10.1038/s41467-020-18042-2

Retinoids regulate a wide spectrum of cellular functions from the embryo throughout adulthood, including cell differentiation, metabolic regulation, and inflammation. These traits make retinoids very attractive molecules for medical purposes. In light of some of the physicochemical limitations of retinoids, the development of drug delivery systems offers several advantages for clinical translation of retinoid-based therapies, including improved solubilization, prolonged circulation, reduced toxicity, sustained release, and improved efficacy. In this Review, we discuss advances in preclinical and clinical tests regarding retinoid formulations, specifically the ones based in natural retinoids, evaluated in the context of regenerative medicine, brain, cancer, skin, and immune diseases. Advantages and limitations of retinoid formulations, as well as prospects to push the field forward, will be presented.